On Saturday, Affymax, Inc. and Takeda Pharmaceutical Company issued a recall for the drug Omontys. Omontys, also referred to by its generic name peginesatide, is used to treat anemia is dialysis patients. The product was recalled after reports of severe allergic reactions, including some fatal reactions.

The U.S. Food and Drug Administration (FDA) has received 19 reports of anaphylaxis, a severe allergic reaction from U.S. dialysis centers, three of which resulted in death. Some of the patients were able to be resuscitated by doctors.

The allergic reactions occurred in patients within 30 minutes of receiving their first doses of the drug by intravenous injection. At this time, there have been no reports of reactions in subsequent doses or in patients that have finished their dialysis session.

All lots of Omontys, sold in 10 milligram and 20 milligram vials, have been recalled. Healthcare professional have been advised to stop using the drug.

Last March, the FDA approved of Omontys for use in the U.S .


If you or a loved one has suffered an allergic reaction to Omontys, you may be eligible for legal and financial recourse. The Eichholz Law Firm offers free legal consultations to all individuals that have been injured by a dangerous drug.

To speak with an attorney about your injury or illness, fill out the Free Case Review form.